Back to Trades
Matsuda Masaru
See RemarksCIK 0001798679
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 20
- Companies
- 1
- Active
- 2025–2026
Matsuda Masaru, See Remarks, has filed 11 SEC reports (2025–2026), all concentrated in Arcutis Biotherapeutics, Inc. (ARQT), totaling $5.5M in disclosed volume. Weighing $0 bought versus $2.9M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Sep 18 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $91.9K |
| Sep 10 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $250.0K |
| Aug 5 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $32.1K |
| May 6 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $192.4K |
| Mar 3 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $313.9K |
| Feb 4 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $1.0M |
| Dec 3 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $50.1K |
| Nov 21 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $72.1K |
| Nov 5 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $178.2K |
| Sep 8 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $583.7K |
| Aug 5 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | $90.7K |
11 filings